<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30327" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Deadly Single Dose Agents</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Euwema</surname>
            <given-names>Michael S.</given-names>
          </name>
          <aff>Orange Park Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Swanson</surname>
            <given-names>Terrell J.</given-names>
          </name>
          <aff>Orange Park Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Euwema declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Terrell Swanson declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>31</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30327.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Although the basics of evaluating and treating most unknown ingestants are well known, many overdoses require very specific treatment if the patient is to have any chance of survival. Despite widespread public education, childproof containers, and other safety measures, accidental overdoses continue to occur. In the United States, poison control centers receive over 2.2 million calls each year, 47% of which concern children less than six years of age. Most pediatric accidental ingestions involve cosmetics and personal care products, followed by cleaning products, and then analgesics and prescription medications. Adult overdoses usually are due to the intentional ingestion of analgesics and sedative-hypnotics. This activity reviews the deadly single dose toxic agents and discusses the interprofessional team's role in educating families on protecting children from exposure to these agents.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Outline the challenges of public education in regard to preventing overdoses.</p></list-item><list-item><p>Identify the common causes of pediatric and adult overdoses.</p></list-item><list-item><p>Describe the common interventions for single-dose agent overdoses.</p></list-item><list-item><p>Review the interprofessional team's role in educating families on protecting children from exposure to these deadly single-dose toxic agents.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30327&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30327">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30327.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Although the basics of evaluating and treating most unknown ingestants&#x000a0;are&#x000a0;well known, many overdoses require very specific treatment if the patient is to have any chance of survival.<xref ref-type="bibr" rid="article-30327.r1">[1]</xref> Countless studies have been published supporting Dr. Gideon Koren's 1993 landmark article "Medications Which Can Kill a Toddler with One Tablet or Teaspoonful" in the Journal of Toxicology.<xref ref-type="bibr" rid="article-30327.r2">[2]</xref><xref ref-type="bibr" rid="article-30327.r3">[3]</xref><xref ref-type="bibr" rid="article-30327.r4">[4]</xref><xref ref-type="bibr" rid="article-30327.r5">[5]</xref>&#x000a0;while each has its own merits, most focus solely on pediatric overdoses, and relatively few of them provide an exhaustive list or act as a "quick-reference" when dealing with real-time ingestions.&#x000a0;</p>
        <p>Despite widespread public education, childproof containers, and other safety measures, accidental overdoses continue to occur.&#x000a0; In the United States, poison control centers receive over 2.2 million calls each year, 47% of&#x000a0;which&#x000a0;concern children less than six years of age.&#x000a0; Most pediatric accidental ingestions involve cosmetics and personal care products, followed by cleaning products, and then analgesics and prescription medications.&#x000a0; Adult overdoses usually are due to the intentional ingestion of analgesics and sedative-hypnotics.&#x000a0;</p>
        <p>Following are the list of toxic drugs (in decreasing severity/difficulty of treatment) included in this summary:&#x000a0;</p>
        <list list-type="order">
          <list-item>
            <p>Alpha-2 adrenergic agonists - clonidine, naphazoline, oxymetazoline, tetrahydrozoline</p>
          </list-item>
          <list-item>
            <p>Sulfonylureas - chlorpropamide, glyburide, glipizide, glimepiride</p>
          </list-item>
          <list-item>
            <p>Calcium channel blockers - nifedipine, verapamil, diltiazem, amlodipine, nicardipine</p>
          </list-item>
          <list-item>
            <p>Beta-blockers - metoprolol, labetalol</p>
          </list-item>
          <list-item>
            <p>Tricyclic antidepressants - imipramine, desipramine, amitriptyline, nortriptyline</p>
          </list-item>
          <list-item>
            <p>Opioids - codeine, hydrocodone, methadone, morphine, heroin</p>
          </list-item>
          <list-item>
            <p>Anti-diarrheals - diphenoxylate + atropine, loperamide</p>
          </list-item>
          <list-item>
            <p>Salicylates/Methyl salicylates - wintergreen oil, bismuth subsalicylate, mentholated balms</p>
          </list-item>
          <list-item>
            <p>Antipsychotics - loxapine, thioridazine, chlorpromazine</p>
          </list-item>
          <list-item>
            <p>Antimalarials - chloroquine, hydroxychloroquine, quinine</p>
          </list-item>
          <list-item>
            <p>Antiarrhythmics - quinidine, disopyramide, procainamide, flecainide</p>
          </list-item>
          <list-item>
            <p>Terpenoid (camphor) - analgesic, anti-itch, and cooling gels, ointments, and balms</p>
          </list-item>
          <list-item>
            <p>Non-alkaloid toxic lignan - podophyllin, podofilox</p>
          </list-item>
          <list-item>
            <p>Plant toxin/secondary metabolite - colchicine</p>
          </list-item>
          <list-item>
            <p>Oral acetylcholinesterase inhibitors - rivastigmine, donepezil, galantamine</p>
          </list-item>
          <list-item>
            <p>Methylxanthine - theophylline: 1,3-dimethylxanthine</p>
          </list-item>
          <list-item>
            <p>Partial opioid agonist/synthetics - buprenorphine/fentanyl</p>
          </list-item>
          <list-item>
            <p>Toxic alcohols - methanol, ethylene glycol</p>
          </list-item>
          <list-item>
            <p>Caustics /household products - acidic or alkaline household products, hydrofluoric acid, selenious acid, ammonia fluoride, methacrylic acid (cosmetic glue), naphthalene (mothballs)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30327.s3" sec-type="Function">
        <title>Function</title>
        <p>
<bold>Toxicokinetics</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Alpha-2 adrenergic agonists: alpha-2 receptors mediate the transmission of neurotransmitters (acetylcholine &#x00026; norepinephrine) across the synapse, effectively antagonizing them</p>
          </list-item>
          <list-item>
            <p>Sulfonylureas: stimulates the pancreas to increase insulin production</p>
          </list-item>
          <list-item>
            <p>Calcium channel blockers: decrease cardiac inotropy and increase vasodilation; can also block insulin secretion in the setting of overdose, which can directly affect the heart&#x000a0;and thereby worsening&#x000a0;shock</p>
          </list-item>
          <list-item>
            <p>Beta-blockers: direct action on the heart causing bradycardia (less severe in children); blockage of gluconeogenesis leading to hypoglycemia; central nervous system (CNS) depression (crosses blood-brain barrier due to high lipid solubility)</p>
          </list-item>
          <list-item>
            <p>Tricyclic antidepressants: block fast sodium channels, leading to intraventricular conduction delay; wide QRS and right axis deviation on EKG</p>
          </list-item>
          <list-item>
            <p>Opioids: direct suppression of CNS respiratory center leading to hypoxic respiratory failure</p>
          </list-item>
          <list-item>
            <p>Anti-diarrheals: biphasic toxicity - first anticholinergic effects and then a longer-lasting opioid effect</p>
          </list-item>
          <list-item>
            <p>Salicylates/Methyl salicylates: direct stimulation of CNS respiratory center (respiratory alkalosis) then metabolic acidosis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Antipsychotics: block post-synaptic dopamine receptors and the reticular activating system (also some serotonin antagonism)</p>
          </list-item>
          <list-item>
            <p>Antimalarials: sodium channel blockade; QRS widening</p>
          </list-item>
          <list-item>
            <p>Antiarrhythmics: sodium channel blockade; QRS widening</p>
          </list-item>
          <list-item>
            <p>Terpenoid (camphor): topical rubefacient induces local hyperemia and warmth</p>
          </list-item>
          <list-item>
            <p>Non-alkaloid toxic lignans: interrupt cell mitosis by binding to tubulin and&#x000a0;disrupting the microtubular network, thereby&#x000a0;disturbing cellular protein assembly and leading to sepsis and multisystem organ failure</p>
          </list-item>
          <list-item>
            <p>Plant toxins/secondary metabolites: same as the lignan. Interrupt cell mitosis by binding to tubulin&#x000a0;and&#x000a0;disrupting the microtubular network, thereby&#x000a0;disturbing cellular protein assembly and leading to sepsis and multisystem organ failure</p>
          </list-item>
          <list-item>
            <p>Oral acetylcholinesterase inhibitors: act on nicotinic and muscarinic receptors; cholinergic toxidrome</p>
          </list-item>
          <list-item>
            <p>Methylxanthines: inhibit phosphodiesterase enzymes which increase cAMP and cGMP to cause bronchodilation</p>
          </list-item>
          <list-item>
            <p>Partial opioid agonist/synthetics: direct suppression of CNS respiratory center (one lick can be enough to be toxic in a child)<xref ref-type="bibr" rid="article-30327.r6">[6]</xref></p>
          </list-item>
          <list-item>
            <p>Toxic alcohols: metabolized into toxic chemicals like aldehyde, organic acids, acetone</p>
          </list-item>
          <list-item>
            <p>Caustics/household products: direct mucosal and pulmonary damage (toxicity related to pH &#x0003c; 3 and &#x0003e; 13), methemoglobinemia (methacrylic acid), cyanide (a metabolite of acrylonitrile)</p>
          </list-item>
        </list>
        <p>
<bold>Symptoms/Physical Findings/Labs/EKG</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Alpha-2 adrenergic agonists: opioid toxidrome, altered mental status</p>
          </list-item>
          <list-item>
            <p>Sulfonylureas: anorexia, weakness, prolonged hypoglycemia up to 18&#x000a0;to 24 hours, lethargy, seizure, coma, headache, confusion, irritability</p>
          </list-item>
          <list-item>
            <p>Calcium channel blockers: hyperglycemia, cardiovascular collapse, bradycardia, hypotension (verapamil and nifedipine worst)<xref ref-type="bibr" rid="article-30327.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p>Beta-blockers: bradycardia and hypotension (generally not as severe in children), hypoglycemia, seizures, reflex tachycardia, 2nd- and 3rd-degree heart block, Torsades de pointes</p>
          </list-item>
          <list-item>
            <p>Tricyclic antidepressants: seizures, anticholinergic toxidrome, hypotension, metabolic acidosis, cardiac conduction abnormalities (QRS prolongation and prominent R in aVR, hypotension, CNS depression, tachycardia then torsades de pointes)</p>
          </list-item>
          <list-item>
            <p>Opioids: hypoxic respiratory failure, miosis, CNS depression</p>
          </list-item>
          <list-item>
            <p>Anti-diarrheals: initially anticholinergic toxidrome then opioid toxidrome; cardiac dysrhythmias, ataxia, irritability, hypokalemia, myopathy, neuropathy, AMS, ocular toxicity, ototoxicity<xref ref-type="bibr" rid="article-30327.r8">[8]</xref></p>
          </list-item>
          <list-item>
            <p>Salicylates/methyl salicylates: nausea and vomiting, diaphoresis, hyperthermia, tinnitus, CNS depression, hyperventilation, primary metabolic acidosis, pulmonary edema, cerebral edema, coma</p>
          </list-item>
          <list-item>
            <p>Antipsychotics: seizures, anticholinergic toxidrome, prolonged QTc, wide QRS, tachycardia, hypotension</p>
          </list-item>
          <list-item>
            <p>Antimalarials: delirium, coma, dysrhythmias, seizures, prolonged QT, widened QRS, hypotension, hypoglycemia, visual disturbances (blurry, diplopia, altered color perception)</p>
          </list-item>
          <list-item>
            <p>Antiarrhythmics: nausea and vomiting, hypotension, QRS widening, heart block, hyperthermia, hypoglycemia, bradycardia, tachyarrhythmias, ventricular tachycardia/fibrillation, torsades de pointes</p>
          </list-item>
          <list-item>
            <p>Terpenoid (camphor): respiratory suppression, status epilepticus, typical odor, GI distress, sense of warmth, CNS hyperactivity, then depression</p>
          </list-item>
          <list-item>
            <p>Non-alkaloid toxic lignan: GI symptoms, CNS changes (confusion, coma, delirium, hallucinations), pancytopenia</p>
          </list-item>
          <list-item>
            <p>Plant toxin/secondary metabolite: Same as lignan. GI symptoms, CNS changes (confusion, coma, delirium, hallucinations), pancytopenia<xref ref-type="bibr" rid="article-30327.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <p>Oral acetylcholinesterase inhibitors: increased level and duration of neurotransmitters</p>
          </list-item>
          <list-item>
            <p>Methylxanthine: vomiting, anxiety, agitation, seizures, ventricular dysrhythmias, hypotension, tachycardia</p>
          </list-item>
          <list-item>
            <p>Partial opioid agonist/synthetics: opioid toxidrome, agitation<xref ref-type="bibr" rid="article-30327.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Toxic alcohols: confusion, vomiting, seizures, hypopnea, cyanosis, hypothermia, syncope</p>
          </list-item>
          <list-item>
            <p>Caustics/household products: drooling, perioral burns, respiratory distress, dysphagia, metabolic effects (methemoglobinemia, hemolysis, cyanide toxicity)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30327.s4" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>
<bold>Treatment/Management (currently recommended&#x000a0;antidotes listed first)</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Alpha-2 adrenergic agonists: naloxone (antidote);&#x000a0;supportive care, airway protection, respiratory support, atropine, IV fluids, vasopressors</p>
          </list-item>
          <list-item>
            <p>Sulfonylureas: octreotide (antidote); serial glucose monitoring, glucagon, GI decontamination, IV dextrose bolus (can overstimulate the pancreas and cause rebound hypoglycemia), 24-hour observation</p>
          </list-item>
          <list-item>
            <p>Calcium channel blockers: high dose Insulin/euglycemic therapy (antidote); other antidotes (weaker evidence) such as lipid emulsion, IV calcium, methylene blue (amlodipine), ECMO for cardiovascular collapse, atropine, cardiac pacing, pressors<xref ref-type="bibr" rid="article-30327.r11">[11]</xref><xref ref-type="bibr" rid="article-30327.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Beta-blockers: glucagon (antidote); monitoring, vasopressors, cardiac pacing, whole bowel irrigation, calcium&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Tricyclic antidepressants: sodium bicarb/lipid emulsion (antidotes); aggressive ABCs, urine alkalinization, activated charcoal, benzodiazepines (may rapidly deteriorate)</p>
          </list-item>
          <list-item>
            <p>Opioids: naloxone (antidote); supportive care, airway protection, respiratory support, 24 hours observation for longer-acting opioids</p>
          </list-item>
          <list-item>
            <p>Anti-diarrheals: naloxone (antidote); fluids, airway support, supportive care</p>
          </list-item>
          <list-item>
            <p>Salicylates/Methylsalicylates: sodium bicarbonate (antidote), urine alkalinization, supportive care, activated charcoal, dialysis. May require long observation (may not peak until 24 hours)</p>
          </list-item>
          <list-item>
            <p>Antipsychotics: sodium bicarbonate&#x000a0;(antidote); supportive care, benzodiazepines, cardiac monitoring, GI decontamination</p>
          </list-item>
          <list-item>
            <p>Antimalarials: sodium&#x000a0;bicarbonate&#x000a0;(antidote); ECMO, supportive care, benzodiazepines, cardiac monitoring, glucose (severe &#x02013; epinephrine, intubation, gastric lavage)</p>
          </list-item>
          <list-item>
            <p>Antiarrhythmics: sodium&#x000a0;bicarbonate&#x000a0;(antidote); supportive care, cardiac monitoring, intravenous fluid bolus</p>
          </list-item>
          <list-item>
            <p>Terpenoid (camphor): supportive care; benzodiazepines, airway monitoring, remove chemical if possible</p>
          </list-item>
          <list-item>
            <p>Non-alkaloid toxic lignan: supportive care; remove topicals, GI decontamination&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Plant toxin/secondary metabolite: supportive care; remove topicals, GI decontamination</p>
          </list-item>
          <list-item>
            <p>Oral acetylcholinesterase inhibitors:&#x000a0;atropine, 2-PAM (pralidoxime), and diazepam</p>
          </list-item>
          <list-item>
            <p>Methylxanthine: supportive care; IV fluids, benzodiazepines, antiemetics, activated charcoal, inotropes</p>
          </list-item>
          <list-item>
            <p>Partial opioid agonist/synthetics:&#x000a0;naloxone (antidote); supportive care, airway protection, respiratory support</p>
          </list-item>
          <list-item>
            <p>Toxic alcohols: ethanol, fomepizole (antidote); supportive care, specific treatment depends on the type of alcohol</p>
          </list-item>
          <list-item>
            <p>Caustics/household products: (multiple specific treatments) supportive care, airway protection, dilution, cyanide kit, methylene blue</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30327.s5" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Although there is little primary research into poisonings, there are numerous case reports and summary articles on the topic.&#x000a0;Novel therapies are in development and testing all the time; for example, methylene blue in amlodipine overdose and &#x0201c;old&#x0201d; therapies such as ECMO are seeing more use and with greater success.<xref ref-type="bibr" rid="article-30327.r13">[13]</xref><xref ref-type="bibr" rid="article-30327.r14">[14]</xref>&#x000a0;In treating patients, be sure to liberally utilize the regional poison control center to ensure the use of the latest therapies and best management available. Toxicologists are always standing by to assist. Also, numerous web resources, such as UpToDate and eMedicine, and textbooks, such as Goldfrank, provide very specific&#x000a0;and current treatment protocols. Observation and supportive care are sufficient for most toxic ingestions, but some, like these highly dangerous substances, require specific treatment and a knowledgeable clinician.</p>
      </sec>
      <sec id="article-30327.s6" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Although identification and proper management of toxic ingestions are vital skills for emergency and acute care clinicians, one cannot forget those that support our mission both before arrival and after treatment and discharge. &#x000a0;Caring for these complicated overdoses is a daunting task, especially for the pre-hospital personnel, as well as those providing aftercare. Numerous studies and articles are now focusing on reducing unnecessary ER visits for minor ingestions&#x000a0;and patient safety, and proper mental health or substance abuse referrals.<xref ref-type="bibr" rid="article-30327.r15">[15]</xref> More evidence-based research is necessary on preventing recidivism, and more collaborative programs need to be developed to provide clear pathways to recovery for the patients&#x000a0;who have intentionally overdosed. As the U.S. opioid crisis has received federal attention (and funding to address it) - now is the time to capitalize on the national momentum to improve our comprehensive care of these patients. &#x000a0;Now is also the time to build our care teams when these patients present to the ER.&#x000a0;A collaboration of EMS, ED providers, clinical pharmacologists, poison control, intensivists, mental health providers, and addiction specialists is necessary for this patient's journey to full recovery.</p>
        <p>Due to the complexity and risk of patients exposed to these agents, an interprofessional team approach will lead to the best outcomes. The nurse should help the clinician obtain an accurate patient and family history, including making calls as necessary to family members and pharmacists. The specialty-trained toxicology pharmacist should evaluate drug-drug interactions, select antidotes, and provide guidance for care to the team. The clinician should consult a clinical toxicologist in most cases to assist in guiding evaluation and therapy. Often a mental health counselor is involved as well. Only by working together as a team will these patients obtain the best care and chance for long-term survival. [Level 5]</p>
      </sec>
      <sec id="article-30327.s7">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30327&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30327">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30327/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30327">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-30327.s8">
        <title>References</title>
        <ref id="article-30327.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erickson</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>The approach to the patient with an unknown overdose.</article-title>
            <source>Emerg Med Clin North Am</source>
            <year>2007</year>
            <month>May</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>249</fpage>
            <page-range>249-81; abstract vii</page-range>
            <pub-id pub-id-type="pmid">17482020</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30327.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koren</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Medications which can kill a toddler with one tablet or teaspoonful.</article-title>
            <source>J Toxicol Clin Toxicol</source>
            <year>1993</year>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>407</fpage>
            <page-range>407-13</page-range>
            <pub-id pub-id-type="pmid">8355317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30327.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bar-Oz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Levichek</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Koren</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Medications that can be fatal for a toddler with one tablet or teaspoonful: a 2004 update.</article-title>
            <source>Paediatr Drugs</source>
            <year>2004</year>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>123</fpage>
            <page-range>123-6</page-range>
            <pub-id pub-id-type="pmid">15035652</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30327.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Braitberg</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Oakley</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Small dose... big poison.</article-title>
            <source>Aust Fam Physician</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>39</volume>
            <issue>11</issue>
            <fpage>826</fpage>
            <page-range>826-33</page-range>
            <pub-id pub-id-type="pmid">21301654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30327.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Michael</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Sztajnkrycer</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Deadly pediatric poisons: nine common agents that kill at low doses.</article-title>
            <source>Emerg Med Clin North Am</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>1019</fpage>
            <page-range>1019-50</page-range>
            <pub-id pub-id-type="pmid">15474780</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30327.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sutter</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Gerona</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Roche</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Colby</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Chenoweth</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Owen</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Ford</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Albertson</surname>
                <given-names>TE</given-names>
              </name>
            </person-group>
            <article-title>Fatal Fentanyl: One Pill Can Kill.</article-title>
            <source>Acad Emerg Med</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>106</fpage>
            <page-range>106-113</page-range>
            <pub-id pub-id-type="pmid">27322591</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30327.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levine</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boyer</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Pozner</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Geib</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Thomsen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mick</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil.</article-title>
            <source>Crit Care Med</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>35</volume>
            <issue>9</issue>
            <fpage>2071</fpage>
            <page-range>2071-5</page-range>
            <pub-id pub-id-type="pmid">17855820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30327.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marraffa</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Oakes</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Wiegand</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Hodgman</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Cardiac conduction disturbance after loperamide abuse.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>52</volume>
            <issue>9</issue>
            <fpage>952</fpage>
            <page-range>952-7</page-range>
            <pub-id pub-id-type="pmid">25345436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30327.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Finkelstein</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Aks</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Hutson</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Juurlink</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dubnov-Raz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pollak</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Koren</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bentur</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Colchicine poisoning: the dark side of an ancient drug.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>48</volume>
            <issue>5</issue>
            <fpage>407</fpage>
            <page-range>407-14</page-range>
            <pub-id pub-id-type="pmid">20586571</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30327.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Geib</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Babu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ewald</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Boyer</surname>
                <given-names>EW</given-names>
              </name>
            </person-group>
            <article-title>Adverse effects in children after unintentional buprenorphine exposure.</article-title>
            <source>Pediatrics</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>118</volume>
            <issue>4</issue>
            <fpage>1746</fpage>
            <page-range>1746-51</page-range>
            <pub-id pub-id-type="pmid">17015570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30327.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>St-Onge</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dub&#x000e9;</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Gosselin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Guimont</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Godwin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Archambault</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Chauny</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Frenette</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Darveau</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Le Sage</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Poitras</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Provencher</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Juurlink</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Blais</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Treatment for calcium channel blocker poisoning: a systematic review.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>52</volume>
            <issue>9</issue>
            <fpage>926</fpage>
            <page-range>926-44</page-range>
            <pub-id pub-id-type="pmid">25283255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30327.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cao</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Heard</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Foran</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Koyfman</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Intravenous lipid emulsion in the emergency department: a systematic review of recent literature.</article-title>
            <source>J Emerg Med</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>48</volume>
            <issue>3</issue>
            <fpage>387</fpage>
            <page-range>387-97</page-range>
            <pub-id pub-id-type="pmid">25534900</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30327.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Lange</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Sikma</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Meulenbelt</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Extracorporeal membrane oxygenation in the treatment of poisoned patients.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>51</volume>
            <issue>5</issue>
            <fpage>385</fpage>
            <page-range>385-93</page-range>
            <pub-id pub-id-type="pmid">23697460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30327.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jang</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Methylene blue in the treatment of refractory shock from an amlodipine overdose.</article-title>
            <source>Ann Emerg Med</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>58</volume>
            <issue>6</issue>
            <fpage>565</fpage>
            <page-range>565-7</page-range>
            <pub-id pub-id-type="pmid">21546119</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30327.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hickey</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Mycyk</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Wahl</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Can a poison center overdose guideline safely reduce pediatric emergency department visits for unintentional &#x003b2;-blocker ingestions?</article-title>
            <source>Am J Ther</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>19</volume>
            <issue>5</issue>
            <fpage>346</fpage>
            <page-range>346-50</page-range>
            <pub-id pub-id-type="pmid">21192245</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
